Resultados de la búsqueda 221-230 of 10670 for monoclonal antibody

  1. Programa de cáncer de pulmón - Ensayos clínicos - Mayo Clinic

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  7. Síntomas y causas - Mayo Clinic

    Descripción general. Diffuse large B-cell lymphoma (DLBCL) is a type of lymphoma. Lymphoma is cancer that affects the lymphatic system.

  8. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  9. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    ... antibodies against microorganisms, and inflammatory markers (e.g., leukocyte esterase, CRP) in synovial fluid for the diagnosis of prosthetic joint ...

  10. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...